CONMED Corporation http://www.alacrastore.com/company-snapshot/CONMED_Corporation-1004120 Friday, September 05, 2008 11:17:40 AM 1004120 CONMED Corporation en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/MW-0001-27899247newstex/MW-0001-27899247xml LONDON, UNITED KINGDOM, Sep. #, #### (Marketwire delivered by Newstex) -- LONDON, UNITED KINGDOM -- (Marketwire) -- ##/##/## -- Reportlinker.com announces that a new market research report related to the Medical devices industry is...0700000007013000130000001301000007014000070140181300400013004001130010001300100204000000040070000400700304016000040160130200000002002000020020089/4/2008 7:24:21 PM18000000180200001802200018015000190000001900200019002004190020091900201319002007190020121900201019002018190010001900104419001021MarketwireMW-0001-27899247BOSTON SCIENTIFIC CORPCONMED CORPCOVIDIEN LTD.BSXCNMDCOVNewsNewstexhttp://www.alacrastore.com/storecontent/spcred/664905spcred/664905normThe latest Summary from S&Pglobal8/13/2008 1:22:00 PM175Summary664905United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe ratings on Utica, N.Y.-based ConMed Corp. reflect the highly competitive nature of its markets with large, well-financed competitors, and its underperforming Endoscopic Technologies division. These concerns partly are offset by the company's position as an important manufacturer in its areas of focus, its product and regional diversity (about 46% of its sales are outside of the U.S.), improvements in its long-struggling Endoscopic Technologies division, and the company's improved financial risk profile in 2007. Standard&Poor's Ratings Services is concerned that the midsize medical products manufacturer--although well established in a number of surgical markets--faces the ongoing challenge of competing against larger, better financed companies such as Smith&Nephew Plc, Stryker Corp., and Covidien Ltd. Disappointment with new products,USA20741C20741035101010 351010 3510 35ConMed Corp.320983USACNMDSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/B1889698ccbn/B1889698norm...Consists of minimally invasive medical devices designed to repair soft tissue injuries in joints such as: ... 7/24/2008 10:14:00 PMCONMED54.0000EditedCONMED Q2 2008 Earnings Conference Call SummaryCNMD10:00am ETBriefB1889698Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1889698ccbn/T1889698norm...Good day, ladies and gentlemen, and welcome to the Second Quarter #### CONMED Corporation Earnings Conference Call. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to your host for today's call, Mr. Josef Corasanti, President and Chief Executive Officer of CONMED. You may proceed, sir. ... 7/24/2008 3:06:00 PMCONMED54.0000FinalCONMED Q2 2008 Earnings Conference Call TranscriptCNMD10:00am ETTranscriptT1889698Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-26389073newstex/BW-0001-26389073xml Jul. #, #### (Business Wire) -- CONMED Corporation (Nasdaq:CNMD) announced today that it expects to report second quarter #### financial results before the market opens on Thursday, July ##, ####, and will also hold a conference call...040000000401600004016018040160480700000007014000070140187/2/2008 11:23:26 AM180000001800400018008000Business WireBW-0001-26389073CONMED CORPCNMDNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1816510ccbn/B1816510norm...Consists of minimally invasive medical devices designed to repair soft-tissue injuries in joints, such as: ... 4/24/2008 2:07:00 PMCONMED54.0000EditedQ1 2008 CONMED Earnings Conference Call SummaryCNMD10:00am ETBriefB1816510Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1816510ccbn/T1816510norm...Good day, ladies and gentlemen, and welcome to the first-quarter #### CONMED earnings conference call. At this time all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of the conference. (OPERATOR INSTRUCTIONS). At this time I would like to turn the presentation over to your host for today's call, Mr. Joseph Corasanti. You may proceed. ... 4/24/2008 12:11:00 PMCONMED54.0000FinalQ1 2008 CONMED Earnings Conference Call TranscriptCNMD10:00am ETTranscriptT1816510Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/bir/25005bir/25005normCONMED Corp.Birtcher Medical Systems Inc.ConMed Andover Medical IncBionx Implants Inc.United StatesManufacturing: Instruments, implants and video equipment for arthroscopic sports medicine and powered surgical instruments, such as drills and saws, for orthopedic, ENT, neuro-surgery and other surgical specialties.3845384138423345103391123391132417GJCNMD4/15/2008 6:14:00 AM25005Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/spcred/632143spcred/632143normThe latest News from S&P2/22/2008 3:33:00 PMNews100global632143United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareNewsBOSTON (Standard&Poor's) Feb. 22, 2008--Standard&Poor's Rating Services said today it raised its senior secured rating on Utica, N.Y.-based ConMed Corp.'s $100 million revolver and $135 million term loan. We raised the senior secured rating to 'BB' (one notch higher than the corporate credit rating on ConMed) from 'BB-' and we changed the recovery rating to '2', indicating the expectation for substantial (70%-90%) recovery in the event of default, from '3'. We also affirmed all other ratings, including the 'BB-' corporate credit rating, on ConMed. The outlook remains positive. "The ratings revision reflects ConMed's senior secured debt reduction throughout 2007," said Standard&Poor's credit analyst Jesse Juliano, "as well as an improvement in the enterprise valueUSA20741020741C35101010 351010 3510 35ConMed Corp.320983USACNMDNEWSGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/632144spcred/632144normThe latest Research Update from S&P2/22/2008 3:33:00 PMResearch Update175global632144United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareResearch UpdateOn Feb. 22, 2008, Standard&Poor's Rating Services raised its senior secured rating on Utica, N.Y.-based ConMed Corp.'s $100 million revolver and $135 million term loan. We raised the senior secured rating to 'BB' (one notch higher than the corporate credit rating on ConMed) from 'BB-' and we changed the recovery rating to '2', indicating the expectation for substantial (70%-90%) recovery in the event of default, from '3'. The ratings revision reflects ConMed's senior secured debt reduction throughout 2007, as well as an improvement in the enterprise value multiple assumption used in our recovery analysis. We also affirmed all other ratings, including the 'BB-' corporate credit rating, on ConMed. The outlook remains positive. The ratings on ConMed reflect theUSA20741020741C35101010 351010 3510 35ConMed Corp.320983USACNMDRESUPDGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/B1745318ccbn/B1745318normQ# #### CONMED Earnings Conference Call2/7/2008 2:10:00 PMCONMED54.0000EditedQ4 2007 CONMED Earnings Conference Call SummaryCNMD10:00am ETBriefB1745318Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1745318ccbn/T1745318normQ# #### CONMED Earnings Conference Call2/7/2008 11:07:00 AMCONMED54.0000FinalQ4 2007 CONMED Earnings Conference Call TranscriptCNMD10:00am ETTranscriptT1745318Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/spcred/624782spcred/624782normThe latest News from S&P1/9/2008 10:47:44 AMNews100global624782United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareNewsNew York (Standard&Poor's) Jan. 9, 2008--Standard&Poor's Rating Services said today that it revised its rating outlook on Utica, N.Y.-based ConMed Corp. to positive from stable. Ratings on the company, including the 'BB-' corporate credit rating, were affirmed. "The outlook revision reflects the company's improved financial risk profile in 2007; cash flow and EBITDA increased while the company repaid debt," said Standard&Poor's credit analyst Jesse Juliano. The revision also reflects our favorable view of ConMed's product diversity and improved performance in its Endoscopic Technologies division. The ratings on ConMed reflect the highly competitive nature of its markets with large, well-financed competitors, and its underperforming Endoscopic Technologies and Patient Care divisions. These concerns partly are offsetUSA20741020741C35101010 351010 3510 35ConMed Corp.320983USACNMDNEWSGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/624783spcred/624783normThe latest Research Update from S&P1/9/2008 10:47:44 AMResearch Update175global624783United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareResearch UpdateOn Jan. 9, 2008, Standard&Poor's Rating Services revised its rating outlook on Utica, N.Y.-based ConMed Corp. to positive from stable. Ratings on the company, including the 'BB-' corporate credit rating, were affirmed. The outlook revision reflects the company's improved financial risk profile in 2007; cash flow and EBITDA increased while the company repaid debt. The revision also reflects our favorable view of ConMed's product diversity and improved performance in its Endoscopic Technologies division. The ratings on ConMed reflect the highly competitive nature of its markets with large, well-financed competitors, and its underperforming Endoscopic Technologies and Patient Care divisions. These concerns partly are offset by the company's position as an important manufacturer in its areas of focus, its productUSA20741020741C35101010 351010 3510 35ConMed Corp.320983USACNMDRESUPDGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/moodys/PR_145156_600041076moodys/PR_145156_600041076htmlRating Action11/29/2007 12:16:12 AMGlobal Credit Research Rating Action ## NOV #### Rating Action: ConMed Corporation Moody's changes ConMed's rating outlook to stable from negative. Approximately $### million of affected debt New York, November ##, #### -- Moody's...ConMed Corporation600041076150.0000NewshtmlConMed CorporationPR_145156_600041076Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/moodys/COP_600041076moodys/COP_600041076htmlCredit Opinion11/28/2007 8:10:09 PMGlobal Credit Research Credit Opinion ## NOV #### Credit Opinion: ConMed Corporation ConMed Corporation Utica, New York, United States Ratings Category Moody's Rating Outlook Stable Corporate Family Rating Ba# Sr Sec Bank Credit Facility...ConMed Corporation600041076150.0000NewshtmlConMed CorporationCOP_600041076Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/spcred/612513spcred/612513normThe latest Full Report from S&P11/9/2007 6:31:02 PMFull Report400global612513United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareFull ReportPosition as an important manufacturer in its areas of focus; and Relatively diverse product offerings. Competes against larger, better-financed companies, Some product shortfalls, and Declining operating margins and cash flow. The ratings on Utica, N.Y.-based ConMed Corp. reflect Standard&Poor's Ratings Services' concern that the midsize medical products manufacturer, although well established in a number of surgical markets, faces the ongoing challenge of competing against larger, better-financed companies. ConMed competes with much larger companies that have broader offerings. The rating also reflects product shortfalls and declining operating margins. These concerns partly are offset by the company's position as an important manufacturer in its areas of focus, and expanded niche offerings. Disappointment with new products, manufacturing difficulties, and new investmentsUSA20741020741C35101010 351010 3510 35ConMed Corp.320983USACNMDFULLGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/612517spcred/612517normThe latest Summary from S&P11/9/2007 6:31:02 PMSummary175global612517United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe ratings on Utica, N.Y.-based ConMed Corp. reflect Standard&Poor's Ratings Services' concern that the midsize medical products manufacturer, although well established in a number of surgical markets, faces the ongoing challenge of competing against larger, better-financed companies. ConMed competes with much larger companies that have broader offerings. The rating also reflects product shortfalls and declining operating margins. These concerns partly are offset by the company's position as an important manufacturer in its areas of focus, and expanded niche offerings. Disappointment with new products, manufacturing difficulties, and new investments to expand its sales force contributed to a decline in operating margins in the past. Adjusted margins peaked at 28% several years ago, but declined to about 13% in 2006.USA20741020741C35101010 351010 3510 35ConMed Corp.320983USACNMDSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/B1665717ccbn/B1665717norm10/25/2007 2:11:00 PMCONMED54.0000EditedQ3 2007 CONMED Earnings Conference Call SummaryCNMD10:00am ET...Sales in the fastest growing product lines representing approx. two-thirds of the business increased #.#% over #Q##. www.streetevents.comContact Us ... BriefB1665717Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1665717ccbn/T1665717norm10/25/2007 11:07:00 AMCONMED54.0000FinalQ3 2007 CONMED Earnings Conference Call TranscriptCNMD10:00am ET...Good day ladies and gentlemen and welcome to the third quarter #### CONMED earnings conference call. My name is Annie, and I will be your coordinator for today. At this time all participants are in a listen-only mode. We will be conducting a question-and-answer session towards the end of this conference. If anytime during the call you require assistance, press star followed by zero and a coordinator will be happy to assist you. As a reminder, this conference is being recorded for replay purposes.I would now like to turn the presentation over your host for today's call, Mr. Joseph Corasanti, President and CEO. Please proceed, sir.... TranscriptT1665717Credit & Investment ResearchThomson Street Events